21-Oct-2026 ECOG-ACRIN announces a national trial of ivonescimab for first-line treatment of advanced biliary tract cancer ECOG-ACRIN Cancer Research Group Business Announcement
21-Oct-2026 Artificial intelligence aids in the development of new active ingredients Helmholtz Centre for Infection Research Peer-Reviewed Publication
21-Oct-2026 Cancer research: Quercetin slows down lung cancer cells Friedrich-Alexander-Universität Erlangen-Nürnberg Peer-Reviewed Publication
21-Oct-2026 Transparent minispheres reveal that some look-alike cancer drugs part ways in 3D Uppsala University Peer-Reviewed Publication
21-Oct-2026 Scientists discover hidden weaknesses in microtubules stabilized by a cancer drug Nano Life Science Institute (NanoLSI), Kanazawa University Peer-Reviewed Publication
21-Oct-2026 Three-week radiation course a safe option for breast cancer patients undergoing reconstruction, Alliance trial shows Alliance for Clinical Trials in Oncology Peer-Reviewed Publication
20-Oct-2026 AI identifies tumor aging patterns to predict immunotherapy response Pohang University of Science & Technology (POSTECH) Peer-Reviewed Publication
20-Oct-2026 Nutritional supplement may help ease ‘brain fog’ after breast cancer treatment University of California - Los Angeles Health Sciences Peer-Reviewed Publication
20-Oct-2026 Brazilian biobank may help personalize cancer prevention in the public health system Fundação de Amparo à Pesquisa do Estado de São Paulo Peer-Reviewed Publication
20-Oct-2026 Dana-Farber presents Phase 3 lung cancer data in ESMO Presidential Symposium Dana-Farber Cancer Institute Reports and Proceedings